Product Images Terazosin

This is a figure showing the results of Study 1. The figure displays the mean change in total symptom score from baseline and the mean increase in peak flow rate (measured in mL/sec) from baseline for the placebo group and the Terazosin treatment group over a period of 3 months. The table below the graph indicates that the Terazosin group had a significant improvement in symptoms and peak flow rate compared to the placebo group (p

This is a graph, labeled as Figure 2, showing the mean change in total symptom score from the baseline in a long-term, non-placebo controlled study with 194 participants. There is a line graph documenting percent change from baseline in which the x-axis represents time intervals in weeks (from 6 to 30), and the y-axis represents the percent change. The graph notes that there was a significant difference (p < 0.05) compared to the baseline, where the mean baseline was 10.7.*

This is a graph labeled Figure 3 that displays the mean change in peak flow rate from baseline over a long-term, open-label, non-placebo controlled study. The x-axis shows the months of the study (ranging from 0 to 30 months) and the y-axis displays the mean change in peak flow rate. The asterisk indicates statistical significance at a p-value of less than 0.05 compared to baseline. The mean baseline is reported as 9.9.*

This text appears to be the label of a capsule medication called Terazosin, manufactured by AIDAREX PHARMACEUTICALS LLC. It contains 9mg of Terazosin and is a generic for Hytrin. The capsule is beige and oblong in shape. There are instructions for dosage, which includes taking the medication every few hours. The manufacturer of the medication is Apotex Inc. from Canada.*

This is a description of a medicine called Terazosin, manufactured by AIDAREX PHARMACEUTICALS LLC with the NDC code 33261-0212-30. It is a capsule with a yellow oblong shape, identified with "WU/ APO 115" on one side and "TERAZOSN 2mg 30" on the other side. Each capsule contains 2mg of Terazosin Hydrochloride. It is a generic for Hytrin (NDC. 33613) and its recommended dose is every few hours a day. The manufacturer is APOTEX INC. from Ontario, Canada.*

This is a medication called Terazosin, which is available in capsule form with a strength of 10mg. It is generic for a drug called Hytrin and is distributed by AIDAREX PHARMACEUTICALS LLC. The medication should be taken several times a day and should be kept in a temperature-controlled room. Information about the manufacturer and NDC codes are also provided.*